Globally, over 1.2 million children under 20 years are living with Type 1 Diabetes Mellitus (T1DM).1 T1DM, sometimes referred to as insulin-dependent diabetes mellitus, is caused by an autoimmune response in which the body’s immune system attacks the beta cells of the islets of Langerhans, resulting in an inability to produce sufficient insulin for metabolic functions.2 The International Diabetes Federation indicates that Africa is home to over 50,000 children living with T1DM, while in Uganda, over 3000 children and adolescents live with T1DM.1 This evidence concerns the gene INS and diabetes mellitus.